PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide and non-selective melanocortin receptor agonist derived from Melanotan II. Unlike peripheral vasoactive compounds, PT-141 — available when you buy PT-141 for sale — acts centrally through MC3R and MC4R receptors in the hypothalamus, engaging neural arousal circuits rather than vascular pathways.
Researchers who buy PT-141 typically use it to investigate melanocortin signaling, central nervous system arousal models, and comparative pharmacology versus peripheral mechanisms. For deeper background, see our PT-141 peptide research guide and complete guide to peptides.
Detailed Mechanism of Action
Researchers who buy PT-141 are working with a compound that operates through a mechanism fundamentally distinct from peripheral agents. PT-141 is a non-selective melanocortin receptor agonist with primary activity at MC3R and MC4R subtypes, both densely expressed in the hypothalamus and limbic regions of the central nervous system. When administered, PT-141 crosses into CNS-relevant compartments and engages MC4R-bearing neurons in the medial preoptic area and paraventricular nucleus.
Activation of MC4R triggers Gs-coupled adenylyl cyclase signaling, elevating intracellular cAMP and modulating downstream neurotransmitter release — particularly dopaminergic signaling within mesolimbic arousal circuits. This pharmacology is why PT-141 research peptide data consistently shows central, pathway-specific effects rather than peripheral vascular changes.
The molecule itself is a cyclic seven-amino-acid analog of alpha-MSH, engineered for receptor stability and systemic exposure. Its cyclic structure resists enzymatic degradation relative to linear melanocortin analogs, which is one reason researchers prefer to buy PT-141 for sale in lyophilized form — the stability profile simplifies reconstitution and dose-response work.
For reconstitution protocols and carrier selection, review our reconstitution guide and peptide dosage calculator tutorial.
Published Research
The published literature on PT-141 (Bremelanotide) spans more than two decades. Early work by Pfaus and colleagues (2004) characterized the compound’s central arousal effects in rodent models, distinguishing it pharmacologically from PDE5 inhibitors. Diamond et al. (2006) reported clinical observations in male subjects, followed by Safarinejad’s 2008 evaluation of tolerability in female arousal disorder cohorts — work that ultimately underpinned the regulatory pathway for Bremelanotide.
Kingsberg and colleagues (2019) published the pivotal data supporting the compound’s approval as a therapeutic, demonstrating reproducible endpoints in hypoactive sexual desire disorder cohorts. This 2019 FDA approval of the pharmaceutical form (Vyleesi®) validated the MC4R-centric mechanism that earlier preclinical research had proposed.
For researchers comparing PT-141 USA 2026 availability with historical literature datasets, the combination of CNS-targeted mechanism and published clinical translation makes this peptide a well-characterized reference compound. Primary literature is indexed on PubMed under “bremelanotide” and at the NIH National Library of Medicine.
PT-141 vs Alternatives
| Feature |
PT-141 |
Melanotan II |
Kisspeptin-10 |
| Primary Target |
MC3R / MC4R |
MC1R / MC3R / MC4R / MC5R |
GPR54 (KISS1R) |
| Mechanism Site |
Central (CNS) |
Central + peripheral |
Hypothalamic (GnRH) |
| Structure |
Cyclic heptapeptide |
Cyclic heptapeptide |
Linear decapeptide |
| Pigmentation Effect |
Minimal (weak MC1R) |
Pronounced (strong MC1R) |
None |
| Clinical Translation |
FDA-approved (Vyleesi®) |
Research only |
Research only |
| Typical Solvent |
Bacteriostatic water |
Bacteriostatic water |
Bacteriostatic water |
| Half-Life |
~2 hours |
~33 hours |
~30 minutes |
| Receptor Selectivity |
Moderate |
Broad / non-selective |
Highly selective |
Reconstitution & Handling
To prepare PT-141 for bench work, reconstitute the 10 mg vial with bacteriostatic water. A common working dilution uses 2 mL BAC water, yielding 5 mg/mL — which simplifies small-volume dose aliquoting in preclinical models. Slowly inject the diluent down the inside wall of the vial rather than directly onto the lyophilized cake; swirl gently until fully dissolved. Do not shake.
After reconstitution, store the solution at 2–8°C and use within 30 days for best stability. For a step-by-step protocol, see the peptide reconstitution guide, and to understand solvent selection, read what is bacteriostatic water.
Storage & Stability
Lyophilized PT-141 should be stored at -20°C protected from light. Under these conditions, the peptide remains stable for up to 24 months. Once reconstituted, refrigerate at 2–8°C, minimize repeated warming, and avoid freeze-thaw cycles that can fragment the cyclic backbone.
Light exposure accelerates oxidation at aromatic residues, so amber vials or foil-wrapped storage is recommended. For signs of degradation and expanded stability data, reference the peptide storage guide and peptide degradation tutorial.
Certificate of Analysis
Every batch ships with a lot-specific Certificate of Analysis (COA) showing HPLC purity, mass spectrometry confirmation of molecular weight, and visual inspection results. Each COA is generated by an independent third-party laboratory — never in-house. For guidance on interpreting COA values, see our how to read a peptide COA article.
Why Researchers Buy PT-141 from PSPeptides
- US Manufactured: Synthesized and lyophilized in American facilities.
- Third-Party Tested: Independent HPLC and mass spectrometry on every batch.
- Fast Shipping: Free UPS 2nd Day Air over $150, same-day before 2 PM EST.
- Flexible Payments: Credit cards, Afterpay, Klarna, Apple Pay, Google Pay.
- 7-Day Support: Email, phone, or text.
Frequently Asked Questions
Where can I buy PT-141 research peptide in the USA?
PSPeptides ships PT-141 USA 2026 orders from domestic fulfillment with US-manufactured inventory. Every vial includes a third-party COA, and orders over $150 ship free via UPS 2nd Day Air.
What is the difference between PT-141 and Melanotan II?
Both are melanocortin receptor agonists, but PT-141 is more selective for MC3R and MC4R with minimal MC1R activity, so pigmentation effects are minimal compared to Melanotan II. Researchers who buy PT-141 also encounter a far shorter half-life (~2 hours vs ~33 hours), which influences study design.
How should PT-141 be reconstituted for research?
Use bacteriostatic water as the diluent. A common working concentration is 5 mg/mL — inject the solvent slowly against the vial wall and swirl gently. See our reconstitution guide for complete step-by-step instructions.
What purity standard does PSPeptides guarantee?
Every batch ships with a lot-specific third-party COA confirming 99%+ purity by HPLC plus molecular weight verification via mass spectrometry. No in-house-only testing — every certificate is independent.
Molecular Structure & Chemistry
Researchers who buy PT-141 are working with a cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, a structural simplification of the parent compound Melanotan II. The intramolecular amide bond between the aspartic acid side chain and the lysine epsilon-amine forms the 23-atom macrocycle that defines the compound’s conformational rigidity. This rigidity is what drives the selectivity shift toward MC3R/MC4R and away from MC1R.
The molecular formula is C50H68N14O10 with a monoisotopic mass near 1024.5 Da. CAS registry 189691-06-3 uniquely identifies Bremelanotide in chemical databases. When you buy PT-141 research peptide in lyophilized form, the solid cake is typically white to off-white with the characteristic fluffy morphology of freeze-dried cyclic peptides.
The presence of D-phenylalanine at position 7 is a deliberate design choice — the D-stereocenter blocks chymotryptic cleavage and extends systemic stability relative to all-L analogs. For a deeper look at peptide structural chemistry, review the peptide glossary.
Pharmacokinetics & Dose-Response Research
Published pharmacokinetic data for subcutaneously administered PT-141 in human research cohorts shows a Tmax around 1.0 hour and a terminal half-life of approximately 2 hours. Plasma protein binding is modest (~21%), and clearance is primarily renal with minimal hepatic CYP-mediated metabolism — a profile researchers often appreciate when planning multi-day dosing windows or investigating drug-drug interaction endpoints.
Dose-response relationships in rodent arousal pathway models show biphasic curves for several behavioral endpoints, with peak effects typically reported in the 0.1 to 1.0 mg/kg range depending on species and route. Researchers who buy PT-141 online for comparative work should plan aliquot volumes that allow clean dose-response construction without repeated vial reconstitution.
For stacking research and combination pharmacology design, review our peptide stacking guide and peptide half-life reference chart. Comparative data on related melanocortin analogs is indexed at PubMed (melanocortin receptor agonist).
Safety Profile in Published Research
Adverse events reported in published PT-141 research peptide literature cluster into three main categories: transient nausea (the most common finding, dose-dependent and self-limited), mild blood pressure elevations of roughly 2–8 mmHg in systolic readings, and skin hyperpigmentation at higher cumulative exposures — the latter driven by residual MC1R activity. These observations informed the eventual regulatory labeling for the pharmaceutical formulation.
In preclinical rodent work, acute toxicity signals are minimal at doses typical for behavioral pharmacology. Chronic-exposure studies show some melanocyte stimulation over extended dosing periods, consistent with the broad melanocortin family’s effect on pigmentation. For a full treatment of peptide-class safety observations, see our peptide side effects guide.
Why the Central Mechanism Matters
The central mechanism of PT-141 is what sets it apart from every peripheral comparator. PDE5 inhibitors and prostaglandin analogs act downstream in vascular smooth muscle; PT-141 acts upstream in the hypothalamic neurons that initiate arousal signaling. This means dose-response data, time-course data, and comparator studies have to be designed around CNS engagement rather than peripheral vasodilation.
From a research planning standpoint, this has two practical consequences. First, route-of-administration matters less for the central pharmacodynamic readout than it does for peripheral agents — subcutaneous and intranasal routes both deliver CNS exposure. Second, pharmacodynamic endpoints need to be chosen carefully: behavioral arousal measures, c-Fos immunohistochemistry in MC4R-rich nuclei, and microdialysis of dopaminergic outputs are all common choices in the published literature.
If you’re planning a comparative study, see our subcutaneous vs intramuscular injection comparison.
Quality Assurance at PSPeptides
When researchers buy PT-141 for sale through PSPeptides, every vial in the shipment has been subjected to a multi-stage QA pipeline. Incoming synthetic material is first characterized by analytical HPLC for purity, then confirmed by LC-MS for molecular weight, and finally assayed for moisture content and residual solvents per ICH Q3C guidelines. Only lots passing all four QA gates are released to inventory.
Each individual vial is lyophilized, capped, and crimped under controlled conditions, then labeled with lot and expiry metadata that ties back to the original COA. Researchers receive a digital copy of the lot-specific COA with every order — no exceptions, no in-house-only certificates, no re-used lot data. For a walkthrough of how to audit a peptide supplier’s documentation, see how to choose a research peptide supplier.
Shipping, Payment & Order Experience
Orders for PT-141 USA 2026 customers are processed same-day when placed before 2 PM EST Monday through Friday. Free UPS 2nd Day Air shipping is included on domestic orders over $150, and faster options are available at checkout. Every shipment is packed with thermal protection appropriate to the product’s stability profile.
PSPeptides accepts all major credit cards plus Afterpay, Klarna, Apple Pay, and Google Pay. Our support team responds seven days a week via email, phone, or text — so if you need COA replacements, batch-history details, or reconstitution guidance, you can reach a human within hours rather than days.
Extended PT-141 FAQ
Is PT-141 legal to purchase for research use in 2026?
Research peptides are legal in the United States when sold and purchased exclusively for non-human laboratory use. PSPeptides ships PT-141 with research-only labeling and requires buyer acknowledgment of research-use-only terms. For current legal-status details, read are research peptides legal 2026.
How does PT-141 compare to the FDA-approved Vyleesi® formulation?
Vyleesi® is a finished pharmaceutical product produced under cGMP with formulated excipients, a specified dose, and a pre-filled autoinjector. Research-grade PT-141 is the isolated active pharmaceutical ingredient supplied as lyophilized powder for laboratory investigation — it is not a finished drug product and is not intended for human administration.
Can PT-141 be stacked with other research peptides?
Researchers occasionally pair PT-141 with unrelated peptides in multi-endpoint studies, but because PT-141 acts centrally through melanocortin receptors, overlap with other MC-family analogs (Melanotan II, for example) can confound interpretation. Our peptide stacking guide covers mechanism-aware combination planning.
What signs indicate PT-141 has degraded?
Visual cues include discoloration of the lyophilized cake (yellowing or browning), visible moisture inside the vial, or turbidity after reconstitution. Chemical cues require HPLC re-analysis. Read peptide degradation: how to tell for a full checklist.
Why is this the best place to buy PT-141 online?
Three reasons researchers consistently cite when choosing PSPeptides for PT-141: every batch is independently third-party tested with the COA included, inventory is US-manufactured rather than repackaged import, and support is staffed seven days a week with real humans. See also the broader best peptide companies 2026 comparison.
PT-141 Research Context & Historical Timeline
The compound now called PT-141 emerged from the alpha-MSH analog work of the 1990s, when peptide chemists at Competitive Technologies and later Palatin Technologies were systematically simplifying Melanotan II to improve receptor selectivity. By the early 2000s, researchers at multiple academic labs recognized that the cyclic heptapeptide retained central nervous system activity while losing much of the peripheral MC1R pigmentation signal — which made it a cleaner tool for arousal-pathway neuroscience.
Between 2004 and 2010 the published literature on PT-141 expanded from basic pharmacology into translational human research, with small-cohort studies establishing tolerability and efficacy endpoints. By 2019 the regulatory translation was complete: Bremelanotide (Vyleesi®) received FDA approval for hypoactive sexual desire disorder in premenopausal women. Researchers who buy PT-141 today are working with a compound that has more than twenty years of peer-reviewed characterization — a level of documentation uncommon for research-grade peptides.
Comparing PT-141 to Other Research Peptides at PSPeptides
Researchers browsing the PSPeptides catalog frequently evaluate PT-141 alongside other peptide families depending on their research question. For muscle recovery and soft-tissue studies, BPC-157 and TB-500 are the typical comparators. For cognitive research, Semax and Selank dominate the nootropic literature.
When researchers buy PT-141, the peptide sits in a comparatively narrow research niche — central melanocortin pharmacology — with Melanotan II as its closest structural relative and Kisspeptin-10 as a pharmacologically distinct but functionally adjacent comparator. Researchers who buy PT-141 online are typically committed to central-arousal-pathway work rather than general-purpose peptide studies. For researchers assembling multi-peptide panels, the stacking guide discusses mechanism-aware combination design.
What Comes When You Buy PT-141
Every time you buy PT-141, the shipment from PSPeptides includes the primary vial of lyophilized peptide, the lot-specific Certificate of Analysis (delivered digitally with order confirmation), and research-use-only labeling. Bacteriostatic water is sold separately and is the recommended reconstitution solvent — see what is bacteriostatic water for selection guidance.
For researchers who want to assemble a complete bench kit when they buy PT-141 for sale, the checkout flow makes it straightforward to add bacteriostatic water, syringes, and alcohol prep pads to the same order. Domestic shipments over $150 qualify for free UPS 2nd Day Air, and all orders ship from US facilities — there is no overseas transit to worry about for PT-141 USA 2026 customers.
Ready to Buy PT-141?
If you’re ready to buy PT-141 for your laboratory, every order ships from US facilities with an independent COA and research-use-only labeling. Researchers who buy PT-141 research peptide from PSPeptides typically restock on the same vendor once they’ve validated a lot — the consistency between batches is what keeps longitudinal studies clean.
For researchers comparing vendors before they buy PT-141 online, the PSPeptides differentiators are straightforward: third-party tested every batch, US manufactured inventory, seven-day support, and flexible payment options. Whether you’re planning a single-lot pilot or a multi-month PT-141 USA 2026 study program, we can accommodate the order size.
Researchers who want to buy PT-141 for sale alongside complementary research materials can bundle bacteriostatic water, syringes, and other consumables into the same checkout. Orders over $150 qualify for free UPS 2nd Day Air. Shop now and get your buy PT-141 and get your shipment in two business days.
Related Resources
All PSPeptides products are sold exclusively for laboratory and research use. Not intended for human consumption.
US Made & Shipped
